The SAFIR-Med project’s vision is to achieve safe, sustainable, socially accepted, and socially beneficial urban air mobility.
SAFIR-Med represents all value chain actors and stakeholders as either project partners (ATC, USPs, Operators, UAS Manufacturers, cities) or formal associate partners (major customers, technology & service providers) at a representative international level. Five unmanned UAV platforms (passenger eVTOL, Hydrogen fuel cell VTOL, AED medical drone, X8 medical transport) will be combined with manned aviation in real-life exercises validating technology in the real urban environment. Technologies from all partners will be leveraged to make use of the maximum number of U-Space services towards the highest possible operational safety level, including advanced Detect And Avoid U-space service.
The demonstrations will take place in the cities of Antwerp (BE), Aachen (DE) and Heerlen (NL), leveraging the MAHHL trans-border region, following a full de-risking exercise at the DronePort BVLOS test-facility in Sint-Truiden, Belgium.
The demonstration results will be further virtually enhanced through large-scale simulations in order to test the maximum airspace capacity of the CONOPS. The project results will then further be validated and made representable for the whole of the EU, by simulating demonstrations in two additional locations in Europe, namely Athens, Greece (South EU) and Prague, Czech Republic (East EU). Lessons learnt will be documented in a Performance Assessment and recommendations report, providing refinements to the current U-space architecture principles and creating measurable indicators for UAM which will enable Smart Cities to include UAM in their Transport Roadmaps, support standardisation and thereby safety. Finally, SAFIR-Med will have made an important contribution to the EU healthcare system, by ensuring that future generations will continue to democratically have access to the best cure and care.